7,569.00

-5.50

-0.07%

51,756.00

-377.00

-0.72%

28,225.50

+98.00

+0.35%

Russell 2000 Futures

2,818.30

+0.50

+0.02%

4.8940

-0.0350

-0.71%

21.59

+0.44

+2.08%

3,924.20

-45.40

-1.14%

77,339.86

-334.38

-0.43%

Crude Oil Dec 26

97.13

+0.67

+0.69%

US Private Equity

10,836.30

-14.33

-0.13%

NasdaqCM - Nasdaq Real Time Price USD

Cardiol Therapeutics Inc. (CRDL)

1.0400 -0.0700 (-6.31%)

At close: November 2 at 4:00:01 PM EST

1.0500 +0.0100 (+0.96%)

Pre-Market: 7:00:07 AM EST

Loading Chart for CRDL

Chart Range Bar

Interval:

In partnership with ChartIQ

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?

Is Cardiol Therapeutics (CRDL) Stock Outpacing Its Medical Peers This Year?

Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?

Cardiol Therapeutics Inc. (CRDL) is a Great Momentum Stock: Should You Buy?

Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial

Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy

Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

5 Small Drug Stocks Poised to Benefit From a Biotech Recovery

Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Is Aspen Pharmacare (APNHY) Outperforming Other Medical Stocks This Year?

Mobilize your Website

View Site in Mobile | Classic

Share by: